VRF EYE SPECIALTY GROUP, PLC
NPI: 1699729806
· MEMPHIS, TN 38120
· 152W00000X
$2.53M
Total Medicaid Paid
Monthly Spending Trend
Yearly Breakdown
| Year | Claims | Total Paid |
|---|
| 2018 |
11,906 |
$296K |
| 2019 |
16,020 |
$343K |
| 2020 |
13,539 |
$397K |
| 2021 |
18,380 |
$468K |
| 2022 |
19,862 |
$458K |
| 2023 |
19,454 |
$380K |
| 2024 |
9,600 |
$191K |
Billing Codes
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 66984 |
|
6,186 |
4,447 |
$491K |
| 67028 |
|
6,799 |
4,403 |
$319K |
| 92014 |
|
7,568 |
6,153 |
$284K |
| 99213 |
|
15,615 |
11,960 |
$213K |
| 92134 |
|
12,740 |
9,231 |
$144K |
| 99214 |
|
6,824 |
4,919 |
$127K |
| 92340 |
|
5,696 |
4,761 |
$125K |
| J9035 |
Bevacizumab injection |
4,115 |
2,816 |
$122K |
| 92004 |
|
2,121 |
1,655 |
$100K |
| 92136 |
|
9,259 |
5,573 |
$74K |
| 92083 |
|
3,690 |
2,982 |
$69K |
| 92015 |
|
4,496 |
3,589 |
$64K |
| S0620 |
Routine ophthalmological exa |
1,576 |
1,239 |
$57K |
| 92133 |
|
4,603 |
3,703 |
$53K |
| 92235 |
|
1,436 |
1,073 |
$32K |
| 92012 |
|
1,593 |
1,164 |
$32K |
| V2020 |
Vision svcs frames purchases |
1,983 |
1,390 |
$30K |
| 93890 |
|
591 |
439 |
$27K |
| 93886 |
|
642 |
468 |
$26K |
| 93892 |
|
615 |
453 |
$26K |
| 99204 |
|
883 |
575 |
$25K |
| 99212 |
|
1,872 |
1,471 |
$19K |
| 92250 |
|
1,208 |
942 |
$18K |
| 99203 |
|
436 |
368 |
$16K |
| V2103 |
Spherocylindr 4.00d/12-2.00d |
1,512 |
721 |
$12K |
| 66183 |
|
57 |
38 |
$7K |
| 99202 |
|
217 |
180 |
$6K |
| 92020 |
|
1,119 |
856 |
$5K |
| 67228 |
|
57 |
24 |
$3K |
| J0178 |
Aflibercept injection |
41 |
24 |
$2K |
| S0621 |
Routine ophthalmological exa |
59 |
54 |
$1K |
| 92225 |
|
144 |
98 |
$1K |
| V2100 |
Lens spher single plano 4.00 |
57 |
27 |
$684.18 |
| 92002 |
|
19 |
13 |
$405.99 |
| 92341 |
|
13 |
13 |
$347.64 |
| 76514 |
|
103 |
85 |
$305.01 |
| V2203 |
Lens sphcyl bifocal 4.00d/.1 |
45 |
12 |
$30.00 |
| V2784 |
Lens polycarb or equal |
2,598 |
1,212 |
$24.00 |
| J7999 |
Compounded drug, noc |
26 |
16 |
$14.63 |
| 99024 |
|
147 |
121 |
$0.00 |